GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.
about
Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytesThe voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MSKv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseasesTargeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitisTargeting Homeostatic T Cell Proliferation to Control Beta-Cell AutoimmunityPotassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal diseasePotassium channels, memory T cells, and multiple sclerosisTargeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseasesThe antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blockerRecurrence of autoimmunity following pancreas transplantation.Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease.HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activationHLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac diseaseThe role of the thymus in tolerance.Proliferation assay amplification by IL-2 in model primary and recall antigen systems.Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.ZnT8-Specific CD4+ T cells display distinct cytokine expression profiles between type 1 diabetes patients and healthy adultsControlling the controls: GAD65 autoreactive T cells in type 1 diabetes.Potent suppression of Kv1.3 potassium channel and IL-2 secretion by diphenyl phosphine oxide-1 in human T cells.Tolerogenic vaccination reduced effector memory CD4 T cells and induced effector memory Treg cells for type I diabetes treatmentLoureirin B, an essential component of Sanguis Draxonis, inhibits Kv1.3 channel and suppresses cytokine release from Jurkat T cellsCD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cellsN-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.Effect of FTY720 on some physiological indexes of Non-Obese Diabetic (NOD) Mice.Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseasesAllelic variant in CTLA4 alters T cell phosphorylation patternsTargeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes.Lovastatin blocks Kv1.3 channel in human T cells: a new mechanism to explain its immunomodulatory propertiesMedullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters.Recurrence of autoreactive antigen-specific CD4+ T cells in autoimmune diabetes after pancreas transplantation.Molecular mechanisms of HLA association with autoimmune diseases.Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant.Differentiation, expansion, and homeostasis of autoreactive T cells in type 1 diabetes mellitus.Voltage-gated potassium channels as therapeutic targets.Detection of GAD65 autoreactive T-cells by HLA class I tetramers in type 1 diabetic patients.Autoimmunity risk alleles in costimulation pathways.Kv1.3 potassium channels as a therapeutic target in multiple sclerosis.Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes.Genetic Susceptibility to Multiple Sclerosis: The Role of FOXP3 Gene Polymorphism.The potential of multimer technologies in type 1 diabetes prediction strategies.
P2860
Q24657847-9B4C60EA-29B0-47D6-B807-C551681C6D90Q24675746-4228FC12-358B-4591-8E19-C2CC716BB042Q24676659-591D5611-57F6-4F1E-8664-C5B33889D937Q24685784-3B094146-81B2-4D35-ADDD-9F13C258064FQ26764999-4D118F45-CC1B-45BA-84E0-6478F225C36EQ28252713-931E2B40-B434-44B5-B7D3-971F14C99220Q28281365-4A5D03A5-BE48-46BB-AF71-B4F1DE7863A1Q28303760-7221B0CA-24C1-46CF-87F5-8EC30E4883CAQ28482737-9852B625-4C48-439E-8791-74E3D2A48331Q33599426-D1A86D1B-1A8A-4A85-8CCA-FB65FB40D87BQ33768325-9512590F-FA56-4038-9A09-43B70EDF4E02Q33892217-AF505DE1-C4A3-4B23-BC46-DB54C4DBA2A3Q33998193-D4396AAD-9ED1-45CD-A200-0974F03C2771Q34103905-BAAAED28-2340-4F7A-85BF-E1E1764057BDQ34309984-059116AB-93D8-45A6-8B41-A799B73117C7Q34311395-5BADD781-B0D4-41F3-9D90-C1D8B308DFE5Q34580119-19C8A988-721C-4980-AB97-B413B8CD4603Q34584056-5C52C2BF-B20B-414E-8A45-200F69CC455AQ34746164-7171146C-647B-432B-B8E0-390DCAF9450CQ34875345-FBA12400-22AD-4F81-9A3F-2F9784202382Q35563291-3C573D05-06F8-4AFF-91A0-861F248998CFQ35679137-4C6F2404-E5C8-4825-96A7-AF6EEBE8F403Q35756367-E2CD56E7-9291-4991-9342-6FEEECCBBBB2Q36057311-F4F2FC5C-DC9A-4F54-9442-B8020C51EDA8Q36097325-74B52A0F-3494-48D9-A5DB-CAAC5705E9F4Q36276908-D41D7E50-652B-424C-839F-E0332F73DA72Q36310443-8B8BC4AD-B970-4004-86B9-0CD2585AA800Q36330011-D608A8B5-E561-4794-B18C-0E419F45E126Q36399006-27A532F1-B736-4A35-8B51-2BD750E1526AQ36865485-F0ADF287-AEA9-468B-A3CF-914C89DDA19FQ37328601-297B7A79-1F69-4559-A6AC-B5A7CD574FCAQ37346963-CE35C697-DE54-49CD-B9A5-30ED154E8892Q37424283-3AE854F0-647F-4A7B-9581-82C4BCF991B4Q37464784-DDBC342D-8FE4-492E-8897-5AE1A7E93DF7Q37474056-3EDD95E2-DBEB-43DC-A910-4A4DD6C81142Q37474977-DD1BD5DC-3A7C-4141-9330-29BD3F13CFF0Q37523986-6A7FD3D1-0F98-43AD-A68C-998760A33D43Q37599880-C9F4871B-4B50-4025-84B9-C1FDB6B32AF8Q37725869-408C931D-8EA1-429A-940E-AB820B43AEF5Q37838895-A43EDAEB-0760-4521-9753-E8AB2CB2E730
P2860
GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.
@ast
GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.
@en
GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.
@nl
type
label
GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.
@ast
GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.
@en
GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.
@nl
prefLabel
GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.
@ast
GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.
@en
GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.
@nl
P2093
P2860
P356
P1476
GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.
@en
P2093
Sally C Kent
Tihamer Orban
Vissia Viglietta
P2860
P304
P356
10.1172/JCI0214114
P407
P577
2002-04-01T00:00:00Z